RORγt Inverse agonist 10 is a highly potent and orally bioavailable compound that acts as an antagonist for the retinoic acid receptor-related orphan nuclear receptor gamma t (RORγt). With an IC50 of 51 nM, it effectively inhibits the activity of RORγt, a prominent transcription factor involved in the regulation of genes associated with the pathogenesis of psoriasis, including IL-17A, IL-22, and IL-23R.

Lucerastat（NBDGJ，芦舍司他）是一种口服的葡萄糖神经酰胺合酶（Glucosylceramide Synthase, GCS）的抑制剂，具有治疗法布里病的潜力。 ​GCS是鞘糖脂合成的关键酶，抑制其活性可减少有害底物的积累。

Varespladib (LY315920) 是选择性group IIA, secretory phospholipase A2(sPLA2)抑制剂，其IC50=9 nM。它对大鼠，兔，豚鼠和人等各种物种血清的sPLA2活性具有明显的抑制作用，IC50分别为 8.1 nM，5.0 nM，3.2 nM 和 6.2 nM。

Methyl gallate (Gallincin) 是具有抗氧化，抗癌和抗炎活性的植物酚类。它也可抑制细菌活性。它还具有抗HIV-1和HIV-1酶的抑制活性。

GGsTop (Nahlsgen) 是一种具有高度选择性和不可逆的 γ 谷酰基转肽酶 (GGT) 抑制剂，具有抗衰老活性。

Mitoquinone mesylate (MitoQ10 mesylate) 是一种有效的TRAP1抑制剂(IC50=0.2 μM）。Mitoquinone mesylate是可防止氧化损伤的抗氧化剂，靶向TPP 的线粒体。

CAY10650 是高效的胞浆磷脂酶A2α抑制剂，IC50=12 nM，能够抑制脂滴形成和 PGE2 分泌。

β-Apo-13-carotenone is a naturally occurring β-apocarotenoid, and is a RXRα antagonist.

Nebicapone is a reversible catechol-O-methyltransferase (COMT) inhibitor and is mainly metabolized by glucuronidation. Nebicapone is mainly peripherally acting inhibitor that decreases the biotransformation of L-DOPA to 3-O-methyl-DOPA by inhibition of CO